Junqi Niu: Influence Statistics

Junqi Niu

Junqi Niu

Department of Hepatology, Center of Infectious Disease and Pathogen Biology, Key laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key ...

Junqi Niu: Expert Impact

Concepts for which Junqi Niu has direct influence: Chronic hepatitis , Hbv dna , Central obesity , Hepatocellular carcinoma , Primary liver cancer , Chronic hepatitis patients , Antiviral therapy .

Junqi Niu: KOL impact

Concepts related to the work of other authors for which for which Junqi Niu has influence: Chronic hepatitis , Hbv rna , Hepatocellular carcinoma , Amap score , Liver fibrosis , Hbsag loss , Hcc patients .

KOL Resume for Junqi Niu

Year
2022

Department of Hepatology, Center of Infectious Disease and Pathogen Biology, Key laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory of Zoonotic Disease, The First Hospital of Jilin University, Changchun, China.

2021

Changchun China

2020

Department of Hepatology, First Hospital, Jilin University, Changchun, China.

2019

Hepatology Unit, No. 1 Hospital affiliated to Jilin University, Changchun, China

2017

The First Bethune Hospital of Jilin University, Chanchun 130062, China

2016

Departments of Hepatology, Ministry of Education Key Laboratory of Zoonosis, Jilin Province Key Laboratory of Infectious Disease, Laboratory of Molecular Virology, Changchun, China

Prominent publications by Junqi Niu

KOL-Index: 17158 . BACKGROUND & AIMS: There is no satisfactory way to identify patients who will maintain a response after discontinuation of nuleos(t)ide analogue therapy for chronic hepatitis B virus (HBV) infection. We investigated whether patients with negative results from tests for HBV DNA and HBV RNA (double negative) at the end of treatment maintain a long-term response to treatment. METHODS: We ...
Known for Hbv Dna | Clinical Relapse | Negative Patients | Antigens Hepatitis
KOL-Index: 12207 . BACKGROUND AND AIM: The prevalence of the hepatitis B virus (HBV) is higher in adults than in children. We determined the seroepidemiology of HBV infection in an adult population in JiLin, China, to guide effective preventive measures. METHODS: A cross-sectional serosurvey was conducted throughout JiLin, China. A total of 3833 people was selected and demographic and behavioral information ...
Known for Northeast China | Hbv Infection | Independent Predictors | Antigens Hepatitis
KOL-Index: 12034 . AIMS: We aimed to develop new simple predictive models for significant fibrosis and inflammation in chronic hepatitis patients using routine laboratory parameters. METHODS: A total of 218 patients who had undergone liver biopsy were enrolled in our study. Among these, 116 had chronic hepatitis B, 65 had primary biliary cirrhosis, and 37 had autoimmune hepatitis. Patients were divided into ...
Known for Chronic Hepatitis | Liver Fibrosis | Blood Cell | Distribution Width
KOL-Index: 10572 . BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is the leading cause of death in patients with chronic hepatitis. In this international collaboration, we sought to develop a global universal HCC risk score to predict the HCC development for patients with chronic hepatitis. METHODS: A total of 17,374 patients, comprising 10,578 treated Asian patients with chronic hepatitis B (CHB), 2,510 ...
Known for Chronic Hepatitis | Amap Score | Hcc Risk | Hepatocellular Carcinoma
KOL-Index: 6777 . Objective To investigate the clinical effect and safety of long-acting pegylated interferon-α-2b (Peg-IFN-α-2b) (Y shape, 40 kD) injection (180 μg/week) in the treatment of HBeAg-positive chronic hepatitis B (CHB) patients, with standard-dose Peg-IFN-α-2a as positive control. Methods This study was a multicenter, randomized, open-label, and positive-controlled phase III clinical trial. ...
Known for Chronic Hepatitis | Pegylated Interferon | Hbeag Positive | 48 Weeks
KOL-Index: 6102 . The transcription factor forkhead box P3 (FOXP3) is essential for the development of regulatory T cells (Tregs) and their function in immune homeostasis. Previous studies have shown that in natural Tregs (nTregs), FOXP3 can be regulated by polyubiquitination and deubiquitination. However, the molecular players active in this pathway, especially those modulating FOXP3 by deubiquitination in ...
Known for Treg Function | Foxp3 Degradation | Immune Homeostasis | Regulatory Cells
KOL-Index: 5844 . Background and aimLong-term treatment with tenofovir disoproxil fumarate (TDF) has demonstrated suppression of viral replication outside of China. This study aims to assess efficacy, resistance and safety of TDF for up to 240 weeks in Chinese patients with chronic hepatitis B virus (HBV) infection.MethodsPatients (HBeAg-positive or HBeAg-negative) who were randomised to receive TDF 300 mg ...
Known for Chronic Hepatitis | Tenofovir Disoproxil Fumarate | Patients Tdf | Hbv Infection
KOL-Index: 5426 . BACKGROUND: Obesity is typically associated with metabolic dysfunction, but its impact on hepatocellular carcinoma (HCC) remains unclear in patients with chronic hepatitis B (CHB). AIM: To study the effect of obesity on HCC development in patients with CHB receiving antiviral therapy. METHODS: We included patients from a Chinese multicentre, prospective, observational, treated CHB cohort ...
Known for Central Obesity | Chronic Hepatitis | Hepatocellular Carcinoma | Hcc Patients
KOL-Index: 5128 . Alpha-fetoprotein (AFP), as the most widely used biomarker of hepatocellular carcinoma (HCC), was correlated with ongoing liver damage. The aim of this study was to evaluate the ability of inflammatory correction-based AFP to identify HCC from other liver diseases.From March 2012 to March 2017, among 926 participants, a total of 501 patients whose transaminases were higher than the upper ...
Known for Hepatocellular Carcinoma | Afp Hcc | Hepatitis Virus | Liver Diseases
KOL-Index: 744 . Objective To explore the related factors for primary hepatic carcinoma (PHC) caused by chronic hepatitis B (CHB) and hepatitis C (CHC). Methods According to the principle of cross-sectional study, a cluster random sample method was used, a total of 366 chronic hepatitis patients in hospitals were recruited from three provincial tertiary hospitals in Shanxi, Henan and Jilin between July ...
KOL-Index: 117
Known for Hepatocellular Carcinoma

Key People For Chronic Hepatitis

Top KOLs in the world
#1
Patrick Marcellin
chronic hepatitis adefovir dipivoxil hcv genotype
#2
Michael Peter Manns
chronic hepatitis liver transplantation hepatocellular carcinoma
#3
Anna Shuk‐Fong Lok
chronic hepatitis hepatocellular carcinoma united states
#4
Stefan S Zeuzem
chronic hepatitis hcv genotype liver fibrosis
#5
Jay H Hoofnagle¶¶
chronic hepatitis liver injury united states
#6
Zachary D Goodman
chronic hepatitis liver fibrosis hepatocellular carcinoma

Department of Hepatology, Center of Infectious Disease and Pathogen Biology, Key laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory of Zoonotic Disease, The First Hospital of Jilin University, Chan